Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction

Papers of special note have been highlighted as: ▪▪ of considerable interest

References

• 1  Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J. Clin. Oncol.15(22),3813–3825 (2004).▪▪ Describes in detail the biology of gastrointestinal stromal tumors (GIST).
  Google Scholar
• 2  Astolfi A, Nannini M, Pantaleo MA et al. A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. Lab. Invest.90,1285–1294 (2010).
  Medline CASGoogle Scholar
• 3  Belinsky MG, Skorobogatko YV, Rink L et al. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes Cancer48,886–896 (2009).
  Medline CASGoogle Scholar
• 4  Pantaleo MA, Astolfi A, Nannini M et al. Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. Histopathology59,1071–1080 (2011).
  MedlineGoogle Scholar
• 5  Janeway KA, Zhu MJ, Barretina J, Perez-Atayde A, Demetri GD, Fletcher JA. Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification. Int. J. Cancer127,2718–2722 (2010).
  Medline CASGoogle Scholar
• 6  Tarn C, Rink L, Merkel E et al. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc. Natl Acad. Sci. USA105,8387–8392 (2008).
  Medline CASGoogle Scholar
• 7  Pantaleo MA, Astolfi A, Di Battista M et al. Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. Int. J. Cancer125,2991–2994 (2009).
  Medline CASGoogle Scholar
• 8  Janeway KA, Kim SY, Lodish M et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc. Natl Acad. Sci. USA108,314–318 (2011).▪▪ First finding of succinate dehydrogenase (SDH) B and SDHC mutations in sporadic KIT/PDGF receptor-α wild-type GIST.
  Medline CASGoogle Scholar
• 9  Pantaleo MA, Astolfi A, Indio V et al. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. J. Natl Cancer Inst.103,983–987 (2011).▪▪ First finding of SDHA mutations in sporadic KIT/PDGF receptor-α wild-type GIST.
  Medline CASGoogle Scholar
• 10  Pantaleo MA, Nannini M, Astolfi A, Biasco G, GIST Study Group Bologna. A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. Am. J. Surg. Pathol.35,1750–1752 (2011).
  MedlineGoogle Scholar
• 11  Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am. J. Surg. Pathol.35,1712–1721 (2011).
  MedlineGoogle Scholar
• 12  Gill AJ, Chou A, Vilain R et al. Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am. J. Surg. Pathol.34,636–644 (2010).
  MedlineGoogle Scholar
• 13  Gill AJ, Chou A, Vilain RE, Clifton-Bligh RJ. ‘Pediatric-type’ gastrointestinal stromal tumors are SDHB negative (‘type 2’) GISTs. Am. J. Surg. Pathol.35,1245–1247 (2011).
  MedlineGoogle Scholar
• 14  Harris AL. Hypoxia – a key regulatory factor in tumour growth. Nat. Rev. Cancer2(1),38–47 (2002).
  Medline CASGoogle Scholar
• 15  Selak MA, Armour SM, MacKenzie ED et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell7,77–85 (2005).
  Medline CASGoogle Scholar
• 16  Franovic A, Holterman CE, Payette J, Lee S. Human cancers converge at the HIF-2α oncogenic axis. Proc. Natl Acad. Sci. USA106,21306–21311 (2009).
  Medline CASGoogle Scholar
• 17  Franovic A, Gunaratnam L, Smith K, Robert I, Patten D, Lee S. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc. Natl Acad. Sci. USA104,13092–13097 (2007).
  Medline CASGoogle Scholar
• 18  Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2α promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell11,335–347 (2007).
  Medline CASGoogle Scholar
• 19  Lorincz A, Redelman D, Horváth VJ, Bardsley MR, Chen H, Ordög T. Progenitors of interstitial cells of cajal in the postnatal murine stomach. Gastroenterology134,1083–1093 (2008).
  MedlineGoogle Scholar
• 20  Favier J, Brière JJ, Strompf L et al. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm. Res.63,171–179 (2005).
  Medline CASGoogle Scholar
• 21  Favier J, Brière JJ, Burnichon N et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One4(9),e7094 (2009).
  MedlineGoogle Scholar
• 22  Linehan WM, Srinivasan R, Schmidt LS. The genetic basis of kidney cancer: a metabolic disease. Nat. Rev. Urol.7,277–285 (2010).
  Medline CASGoogle Scholar
• 23  Rege TA, Wagner AJ, Corless CL, Heinrich MC, Hornick JL. ‘Pediatric-type’ gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Am. J. Surg. Pathol.35,495–504 (2011).
  MedlineGoogle Scholar
• 24  Carney JA, Sheps SG, Go VL et al. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N. Engl. J. Med.296,1517–1518 (1977).
  Medline CASGoogle Scholar
• 25  Chou A, Chen J, Clarkson A et al. Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Mod. Pathol.25(9),1307–1313 (2012).
  Medline CASGoogle Scholar
• 26  Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am. J. Med. Genet.108,132–139 (2002).
  MedlineGoogle Scholar
• 27  Stratakis CA, Carney JA. The triad of parangangliomas, gastric stromal tumors and pulmonary chondromas (Carney triad), and the dyad of parangangliomas and gastric striomal sarcomas (Carney-Stratakis syndrome): a molecular genetics and clinical implications. J. Intern. Med.266,43–52 (2009).
  Medline CASGoogle Scholar
• 28  Zhang L, Smyrk TC, Young WF Jr et al. Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am. J. Surg. Pathol.34,53–64 (2010).
  MedlineGoogle Scholar
• 29  Gaal J, Stratakis CA, Carney JA et al. SDHB immunohistochemistry: a useful tool in the diagnosis of carney-stratakis and carney triad gastrointestinal stromal tumors. Mod. Pathol.24,147–151 (2011).
  Medline CASGoogle Scholar